Baird Financial Group’s LeMaitre Vascular LMAT Stock Holding History
Bought
Maintained
Sold
Other funds holding LMAT
CCA
CAM
CCM
Baird Financial Group's LMAT Position: Q2 2026 in Review
Baird Financial Group reduced its LeMaitre Vascular (LMAT) stake by 57% in Q2 2026, selling an estimated $401K and leaving 2,910 shares worth $279K. The position accounts for ﹤0.01% of the portfolio, ranked #1753.
Baird Financial Group first reported a position in LMAT in Q3 2021 and has held it in 20 quarters since. The position peaked at $744K in Q1 2026. 327 funds tracked by Wall St. Rank hold LMAT as of Q2 2026.
- Baird Financial Group held 2,910 shares of LeMaitre Vascular worth $279K as of Q2 2026.
- Baird Financial Group sold 3,909 LeMaitre Vascular shares in Q2 2026, an estimated $401K.
- LeMaitre Vascular made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1753 holding.
- Baird Financial Group first reported a position in LeMaitre Vascular in Q3 2021 and has held it in 20 quarters since.
- Baird Financial Group's LeMaitre Vascular position peaked at $744K in Q1 2026.
- 327 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q2 2026.
Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.